Natrol, Inc., a Chatsworth, California manufacturer and marketer of
dietary supplements and nutritional products, has been acquired by
Plethico Pharmaceutical Limited of India.1 In November 2007,
one of Plethico’s subsidiaries, Nutra Acquisition Company, signed a
merger agreement with Natrol that stated Plethico would acquire all
outstanding shares of Natrol’s common stock at a price of $4.40 per
share at a total of about $80.8 million.1,2
The transition was approved by Plethico and Natrol’s board of
directors and during the tender offer period, the above mentioned
Plethico subsidiary acquired enough Natrol shares to have a short-term
merger into Natrol without the vote of the remaining Natrol
stockholders.1,2 This acquisition was completed December 27, 2007.
“As a shareholder it is safe to say that all shareholders received a
significant value return based on average trading value over the past
few years,” wrote Elliot Balbert, founder and executive chairman of
Natrol (e-mail, December 24, 2007). “Management fulfilled their
operational responsibilities to deliver value for investment.” However,
this does not mean that Natrol will disappear. It is instead “an
American company that will become privately held by a foreign parent,”
said Balbert.
This merger was attractive to Plethico because, according to Wayne
M. Bos, president and CEO of Natrol (e-mail, January 4, 2008), Plethico
has significant ambition for its global strategy and wanted to enter
the US market. Additionally, according to a statement by Bos in a
Natrol press release, the situation is also a “win-win”1
for Natrol’s customers and employees. “More focus on new innovation
means new and improved technology and products for customers and
greater diversity in job prospects as well as growth for employees,”
wrote Bos.
Bos also noted that this merger will enable Natrol to have greater
access to capital, new markets, and new products. However, this
decision was not made in a business vacuum. “Good business decisions
are made with many elements being considered. All stakeholders
positions are considered, including shareholders, employees, and
customers,” wrote Bos. “The combined companies are on a strong growth
path and all new strategy decisions will need to consider the human and
financial resources.”
Natrol, Inc. was founded by Balbert in 1980 and went public in 1998.
The company has produced and marketed a line of dietary supplements
sold in health food stores and mass market retail outlets under the
Natrol® brand name, as well as producing and/or acquiring such brands
as MRI, Prolab®, Laci Le Beau®, Promensil®, Trinovin®, Nu Hair® and
Shen Min®.3 More information is available at http://www.natrol.com/.
Plethico Pharmaceuticals Limited of Mumbai, India manufactures, markets
and distributes pharmaceuticals and nutritional products in India and
internationally. More information about Plethico is available at http://www.plethico.com/home.html.
—Kelly E. Saxton
References
1Natrol, Inc. agreed to be acquired by India’s Plethico Pharmaceuticals Limited [press release]. Chatsworth, CA: Natrol, Inc. November 19, 2007. 2RTTNews. Plethico Pharma buys Natrol for $4.40 per share-update [NTOL]. Global Financial Newswires. Available at http://www.rttnews.com/sp/breakingnews.asp?date=12/28/2007&item=64&vid=0. Accessed January 4, 2008. 3Natrol. Natrol Mission page. Natrol Web Site. Available at http://www.natrol.com/about/mission-history/. Accessed January 10, 2008. |